Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralymphatic specific immunotherapy as a new treatment method for grass pollen allergy
2010-019160-37Phase 3Completed
- Sponsor
- Allergiklinikken
- Start
- May 2010
- Countries
- 1
01
Overview
Phase 3, single-arm trial of phleum pratense allergen extract in grass pollen allergy and allergic rhinitis (AR), sponsored by Allergiklinikken. Primary endpoints: Symptom and medication use reduction during grass pollen season and Safety. Started May 2010; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
grass pollen allergyallergic rhinitis (AR)
Beyond the preview
Go deeper on 2010-019160-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019160-37.